Volume 38 Issue 9
Sep.  2022
Turn off MathJax
Article Contents
Article Navigation >  Journal of Nanjing University of traditional Chinese Medicine  > 2022  >  38(9): 819-826
WANG Yu-chen, RUI Li-ning, JIA Chuan, YU Wei-zhong. Qianggu Decoction Promotes Angiogenesis through Wnt3a/β-catenin/VEGF Pathway to Improve Osteoporosis in Perimenopausal Rats[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(9): 819-826. doi: 10.14148/j.issn.1672-0482.2022.0819
Citation: WANG Yu-chen, RUI Li-ning, JIA Chuan, YU Wei-zhong. Qianggu Decoction Promotes Angiogenesis through Wnt3a/β-catenin/VEGF Pathway to Improve Osteoporosis in Perimenopausal Rats[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(9): 819-826. doi: 10.14148/j.issn.1672-0482.2022.0819
shu

Qianggu Decoction Promotes Angiogenesis through Wnt3a/β-catenin/VEGF Pathway to Improve Osteoporosis in Perimenopausal Rats

doi: 10.14148/j.issn.1672-0482.2022.0819

  • Chinese Medical Hospital of Wujin Affiliated to Nanjing University of Chinese Medicine, Changzhou 213161, China

  • Received Date: 2021-10-22
    Available Online: 2022-09-19
    Abstract
  •   OBJECTIVE  To investigate the efficacy and possible mechanism of action of the Chinese medicinal preparation Qianggu decoction on perimenopausal osteoporotic SD rats.  METHOD  HPLC was used to establish the standard fingerprint profile of Qianggu decoction. Fifty SD rats were randomly divided into sham-operated group, model group, estradiol valerate group, and high (12 g · kg-1) and low (6 g · kg-1) dose groups of Qianggu decoction, with 10 rats in each group. The perimenopausal osteoporosis rat model was prepared by bilateral ovariectomy method, and saline, estradiol or high and low doses of Qianggu decoction were administered by gavage for 30 days. The weight and uterine weight of the rats were recorded, and the bone mechanics related indexes were measured, and the number of osteoblasts and the area of bone trabeculae in the femur were observed by HE staining. Wnt3a, β-catenin, VEGF and OPG gene expression levels were detected by PCR; VEGFR-2 and CD31 were detected by immunofluorescence, and angiogenesis was evaluated. The protein expression of Wnt3a, p-GSK3β, VEGF, β-catenin, Lamin were detected by Western blot.  RESULTS  The fingerprint similarity of the 10 batches of Qianggu decoction was greater than 0.9, indicating that the quality of the 10 batches of samples was stable. Compared with the model group, estradiol valerate-treated group and high and low dose Qianggu decoction-treated groups could significantly improve the uterine index, bone density and bone mechanical properties of rats(P < 0.05, P < 0.01), significantly improve bone microstructure, and increase the levels of Wnt3a, β-catenin, VEGF, OPG mRNA in femoral tissue(P < 0.05, P < 0.01), as well as VEGF, CD31, Wnt3a, p-GSK3β, β-catenin, Lamin protein expressions(P < 0.05, P < 0.01).  CONCLUSION  Qianggu decoction may regulate VEGF expression and promote angiogenesis through Wnt3a/β-catenin signaling pathway, thus increasing bone density and improving bone tissue morphology in rats, and then exerted anti-osteoporosis effects.

     

    • FullText(HTML)
  • loading
    • References(36)
  • [1]
    马远征, 王以朋, 刘强, 等. 中国老年骨质疏松症诊疗指南(2018)[J]. 中国实用内科杂志, 2019, 39(1): 38-61. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK201901012.htm

    MA YZ, WANG YP, LIU Q, et al. 2018 China guideline for diagnosis and treatment of senile osteoporosis[J]. Chin J Pract Intern Med, 2019, 39(1): 38-61. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK201901012.htm
    [2]
    中华人民共和国国家统计局. 中国统计年鉴2015[M]. 北京: 中国统计出版社, 2015.

    National Bureau of Statistics, PRC. China Statistical Yearbook 2015[M]. Beijing: China statistical publishing house, 2015.
    [3]
    Management of osteoporosis in postmenopausal women: 2010 position statement of the North American Menopause Society[J]. Menopause, 2010, 17(1): 25-56.
    [4]
    陈芳, 张宜, 徐立. 中西医治疗绝经后骨质疏松症的研究进展[J]. 医药导报, 2021, 40(9): 1216-1220. https://www.cnki.com.cn/Article/CJFDTOTAL-YYDB202109013.htm

    CHEN F, ZHANG Y, XU L. Research progress of traditional Chinese and western medicine in the treatment of postmenopausal osteoporosis[J]. Herald Med, 2021, 40(9): 1216-1220. https://www.cnki.com.cn/Article/CJFDTOTAL-YYDB202109013.htm
    [5]
    闫慧明, 郭静, 安燕, 等. 分子信号通路在骨质疏松症发生机制中的研究进展[J]. 中国骨质疏松杂志, 2016, 22(10): 1336-1340. doi: 10.3969/j.issn.1006-7108.2016.10.024

    YAN HM, GUO J, AN Y, et al. Research progress in molecular signaling pathways on the pathogenesis of osteoporosis[J]. Chin J Osteoporos, 2016, 22(10): 1336-1340. doi: 10.3969/j.issn.1006-7108.2016.10.024
    [6]
    王林, 李平, 贾海峰, 等. 兔骨缺损ESW治疗后成骨细胞中VEGF的表达[J]. 中国当代医药, 2009, 16(13): 23-24. doi: 10.3969/j.issn.1674-4721.2009.13.012

    WANG L, LI P, JIA HF, et al. Expression of VEGF on the osteoblast after extracorporeal shock wave (ESW) for the treatment of rabbits bone defect[J]. China Mod Med, 2009, 16(13): 23-24. doi: 10.3969/j.issn.1674-4721.2009.13.012
    [7]
    XU H, YANG JJ, WANG CH, et al. Effect of Wnt/β-catenin signal pathway on of matrix metalloproteinase-7 and vascular endothelial growth factor gene expressions in endometriosis[J]. Clin Exp Obstet Gynecol, 2016, 43(4): 573-577. doi: 10.12891/ceog3053.2016
    [8]
    LI ZN, YUAN GX, LIN XX, et al. Dehydrocostus lactone (DHC) suppresses estrogen deficiency-induced osteoporosis[J]. Biochem Pharmacol, 2019, 163: 279-289. doi: 10.1016/j.bcp.2019.02.002
    [9]
    DU D, ZHOU ZB, ZHU L, et al. TNF-α suppresses osteogenic differentiation of MSCs by accelerating P2Y2 receptor in estrogen-deficiency induced osteoporosis[J]. Bone, 2018, 117: 161-170. doi: 10.1016/j.bone.2018.09.012
    [10]
    PARK E, LIM E, YEO S, et al. Anti-menopausal effects of Cornus officinalis and Ribes fasciculatumextract in vitro and in vivo[J]. Nutrients, 2020, 12(2): E369. doi: 10.3390/nu12020369
    [11]
    FAIENZA MF, VENTURA A, MARZANO F, et al. Postmenopausal osteoporosis: The role of immune system cells[J]. Clin Dev Immunol, 2013, 2013: 575936.
    [12]
    STERN AR, YAO XM, WANG Y, et al. Effect of osteoporosis treatment agents on the cortical bone osteocyte microenvironment in adult estrogen-deficient, osteopenic rats[J]. Bone Rep, 2018, 8: 115-124. doi: 10.1016/j.bonr.2018.02.005
    [13]
    LEVIN VA, JIANG X, KAGAN R. Estrogen therapy for osteoporosis in the modern era[J]. Osteoporos Int, 2018, 29(5): 1049-1055. doi: 10.1007/s00198-018-4414-z
    [14]
    ZHU SY, DENG Y, WANG YF, et al. Bone protection for early menopausal women in China: Standard or half-dose estrogen with progestin?A one-year prospective randomized trail[J]. Gynecol Endocrinol, 2019, 35(2): 165-169. doi: 10.1080/09513590.2018.1505849
    [15]
    TAHAMI M, HADDAD B, ABTAHIAN A, et al. Potential role of local estrogen in enhancement of fracture healing: Preclinical study in rabbits[J]. Arch Bone Jt Surg, 2016, 4(4): 323-329.
    [16]
    SANTEN RJ, SIMPSON E. History of estrogen: Its purification, structure, synthesis, biologic actions, and clinical implications[J]. Endocrinology, 2018, 160(3): 605-625.
    [17]
    NASOMYONT N, HORNUNG LN, GORDON CM, et al. Outcomes following intravenous bisphosphonate infusion in pediatric patients: A 7-year retrospective chart review[J]. Bone, 2019, 121: 60-67. doi: 10.1016/j.bone.2019.01.003
    [18]
    杨茜, 张毅, 张元琛, 等. 强骨合剂联合西药治疗糖尿病骨质疏松症临床观察[J]. 宁夏医学杂志, 2015, 37(3): 281-283. https://www.cnki.com.cn/Article/CJFDTOTAL-NXYX201503042.htm

    YANG X, ZHANG Y, ZHANG YC, et al. Clinical observation of qianggu mixture combined with western medicine in treating diabetic osteoporosis[J]. Ningxia Med J, 2015, 37(3): 281-283. https://www.cnki.com.cn/Article/CJFDTOTAL-NXYX201503042.htm
    [19]
    鄂远. 强骨合剂治疗糖尿病合并骨质疏松症的临床观察[J]. 糖尿病新世界, 2018, 21(20): 93-94. https://www.cnki.com.cn/Article/CJFDTOTAL-TNBX201820047.htm

    ER Y. Clinical observation on treatment of diabetes mellitus with osteoporosis with strong bone mixture[J]. Diabetes New World, 2018, 21(20): 93-94. https://www.cnki.com.cn/Article/CJFDTOTAL-TNBX201820047.htm
    [20]
    王雨辰, 刘百伟, 李云峰, 等. 强骨合剂治疗肾虚血瘀型骨质疏松症的临床研究[J]. 中医药导报, 2016, 22(23): 94-95, 98. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZB201623031.htm

    WANG YC, LIU BW, LI YF, et al. Clinical research on kidney-deficiency and blood-stasis type osteoporosis by qianggu heji[J]. Guid J Tradit Chin Med Pharm, 2016, 22(23): 94-95, 98. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZB201623031.htm
    [21]
    王雨辰, 李云峰, 吴小伟, 等. 强骨合剂治疗肾虚血瘀型原发性骨质疏松症[J]. 长春中医药大学学报, 2015, 31(6): 1215-1217. https://www.cnki.com.cn/Article/CJFDTOTAL-CZXX201506043.htm

    WANG YC, LI YF, WU XW, et al. Treatment of kidney-deficiency and blood-stasis type osteoporosis with Qianggu Decoction[J]. J Changchun Univ Chin Med, 2015, 31(6): 1215-1217. https://www.cnki.com.cn/Article/CJFDTOTAL-CZXX201506043.htm
    [22]
    李万森. 强骨合剂治疗糖尿病骨质疏松症疗效观察[J]. 山东医药, 2009, 49(35): 91-92. doi: 10.3969/j.issn.1002-266X.2009.35.040

    LI WS. Observation on therapeutic effect of Qianggu mixture on diabetic osteoporosis[J]. Shandong Med J, 2009, 49(35): 91-92. doi: 10.3969/j.issn.1002-266X.2009.35.040
    [23]
    LEUCHT P, HELMS JA. Wnt signaling: An emerging target for bone regeneration[J]. J Am Acad Orthop Surg, 2015, 23(1): 67-68. doi: 10.5435/JAAOS-23-01-67
    [24]
    BOONANANTANASARN K, LEE HL, BAEK K, et al. EGF inhibits Wnt/β-catenin-induced osteoblast differentiation by promoting β-catenin degradation[J]. J Cell Biochem, 2015, 116(12): 2849-2857. doi: 10.1002/jcb.25231
    [25]
    REYA T, CLEVERS H. Wnt signalling in stem cells and cancer[J]. Nature, 2005, 434(7035): 843-850. doi: 10.1038/nature03319
    [26]
    KATO M, PATEL MS, LEVASSEUR R, et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor[J]. J Cell Biol, 2002, 157(2): 303-314. doi: 10.1083/jcb.200201089
    [27]
    GONG YQ, SLEE RB, FUKAI NM, et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development[J]. Cell, 2001, 107(4): 513-523. doi: 10.1016/S0092-8674(01)00571-2
    [28]
    王燕, 刘岩, 马剑侠, 等. Wnt/LRP5/β-catenin信号通路在绝经后骨质疏松发病中的作用[J]. 中华妇产科杂志, 2011, 46(10): 769-772. doi: 10.3760/cma.j.issn.0529-567x.2011.10.012

    WANG Y, LIU Y, MA JX, et al. Effect of the Wnt/LRP5/β-catenin signaling pathway on the pathogenesis of postmenopausal osteoporosis[J]. Chin J Obstet Gynecol, 2011, 46(10): 769-772. doi: 10.3760/cma.j.issn.0529-567x.2011.10.012
    [29]
    MILLER JR. The wnts[J]. Genome Biol, 2002, 3(1): 3001.
    [30]
    NUSSE R. Wnt signaling in disease and in development[J]. Cell Res, 2005, 15(1): 28-32. doi: 10.1038/sj.cr.7290260
    [31]
    MACDONALD BT, TAMAI K, HE X. Wnt/beta-catenin signaling: Components, mechanisms, and diseases[J]. Dev Cell, 2009, 17(1): 9-26. doi: 10.1016/j.devcel.2009.06.016
    [32]
    LICHTLEN P, LAM TT, NORK TM, et al. Relative contribution of VEGF and TNF-α in the cynomolgus laser-induced CNV model: Comparing the efficacy of bevacizumab, adalimumab, and ESBA105[J]. Invest Ophthalmol Vis Sci, 2010, 51(9): 4738-4745. doi: 10.1167/iovs.09-4890
    [33]
    HU Y, CHEN Y, LIN MK, et al. Pathogenic role of the Wnt signaling pathway activation in laser-induced choroidal neovascularization[J]. Invest Ophthalmol Vis Sci, 2013, 54(1): 141-154. doi: 10.1167/iovs.12-10281
    [34]
    KATOH Y, KATOH M. Comparative integromics on VEGF family members[J]. Int J Oncol, 2006, 28(6): 1585-1589.
    [35]
    ZHANG X, GASPARD JP, CHUNG DC. Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia[J]. Cancer Res, 2001, 61(16): 6050-6054.
    [36]
    WANG Y, SANG AM, ZHU MH, et al. Tissue factor induces VEGF expression via activation of the Wnt/β-catenin signaling pathway in ARPE-19 cells[J]. Mol Vis, 2016, 22: 886-897.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(6)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (111) PDF downloads(17) Cited by()
    Proportional views
    Related

    Copyright © Journal of Nanjing University of traditional Chinese Medicine

    Sponsored by：Nanjing University of traditional Chinese MedicineAddress：No.138 xianlin Avenue, Qixia District, Nanjing cityChina Pos：210023

    Tel：025-85811935Email：xb@njucm.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return